Award recordCONTRACT

TAKEDA PHARMACEUTICALS AMERICA, INC.

PIID 36C24122F0125· VHA· 241-NETWORK CONTRACT OFFICE 01 (36C241)· Q517 · PHARMACY SERVICES· FY2022· $40,408 net obligations· UEI DDEVYUAXJ624· IL

Description

EMERGENCY: LIVTENCITY MEDICATION FOR KIDNEY TRANSPLANT INFECTION

First action · last action
2022-02-28 · 2024-12-18
Transactions
2
First transaction's obligation
$37,437
Base + all options value (sum of deltas)
$40,408
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50492
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$40,408$0Base award · 2022-02-28 · this action $37,437 · running total $37,437Modification P00001 · 2024-12-18 · this action $2,971 · running total $40,408
  • Base2022-02-28+$37,437= $37,437
  • Mod P000012024-12-18+$2,971= $40,408
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-02-28+$37,437$37,437EMERGENCY: LIVTENCITY MEDICATION FOR KIDNEY TRANSPLANT INFECTION
Mod P00001· OTHER ADMINISTRATIVE ACTION2024-12-18+$2,971$40,408EMERGENCY: LIVTENCITY MEDICATION FOR KIDNEY TRANSPLANT INFECTION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DDEVYUAXJ624)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0840245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$19,139FY2026
36E79726A0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0835245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,605FY2026
36F79726D0181NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026P0420260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$107,540FY2026
36C26126P0581261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$27,250FY2026

Other recipients under Q517 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24126N0442BLISS PHARMACY SERVICES LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$114,715FY2026
36C24126N0481BLISS PHARMACY SERVICES LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$117,940FY2026
36C24126N0437BLISS PHARMACY SERVICES LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$183,730FY2026
36C24126N0515BLISS PHARMACY SERVICES LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$155,370FY2026
36C24126N0366BLISS PHARMACY SERVICES LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$187,200FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24122F0125_3600_V797D50492_3600 · retrieved 2026-09-26.